Joe Payne and Neda Safarzadeh of Arcturus Therapeutics, a San Diego biotech, join us to talk about their progress on developing a vaccine against COVID-19 with a Singapore partner. Joe explains about messenger RNA vaccines, their advantages in safety, manufacturing, and efficiency, as well as regulatory processes and a potential timeline, and why some vaccines have to be modified each year. He also tells us what Arcturus means. A highly educational episode about a critical issue.Arcturus Therapeutics' website:https://arcturusrx.com/Follow Arcturus on Twitter:@ArcturusRxJoe Payne on LinkedIn:https://www.linkedin.com/in/jepayne/Thoughts? Comments? Potshots? Contact the show at:https://www.discreetguide.com/Follow the host on Twitter:@DiscreetGuideThe host on LinkedIn:https://www.linkedin.com/in/jenniferkcrittenden/

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related